Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Eclipse Platelet-Rich Plasma (Eclipse PRP) is an autologous platelet concentration system used to prepare platelet-rich plasma from a patient's own peripheral blood. Marketed by Crown Aesthetics, the system utilizes a patented separator gel technology and centrifugation to isolate a high concentration of platelets while effectively removing red blood cells and inflammatory white blood cells. The therapeutic effect is mediated by the concentrated platelets, which, upon injection or application, release a variety of growth factors including PDGF, TGF-β, VEGF, and EGF. These factors stimulate cellular proliferation, angiogenesis, and collagen synthesis, making the system a staple in aesthetic medicine for skin rejuvenation and hair restoration (androgenetic alopecia), as well as in orthopedic medicine for treating musculoskeletal injuries and osteoarthritis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Eclipse platelet-rich plasma.